Clinical ophthalmology · 2012 · 24 citations · 11 references
Life SciencesImmunologyPharmacotherapyImmunology Of Infectious DiseasesImmunopathologyVirologyAntiviral TherapyViral InfectionsCytomegalovirus DiseaseCytomegalovirus Infection ManagementCytomegalovirus TherapyImmunosuppressive Drug TherapyRemission Induction TherapySerious Adverse EventsSystemic Immunosuppressive TherapyTreatment Of Cytomegalovirus Infection
A case of cytomegalovirus (CMV) retinitis in a patient with Wegener's granulomatosis treated with oral valganciclovir as maintenance therapy is reported. A 68-year-old male patient with anti-proteinase-3 ANCA-positive Wegener's granulomatosis who was receiving immunosuppressive therapy with methylprednisolone, cyclophosphamide, and azathioprine developed CMV retinitis. The patient received intravenous ganciclovir as induction therapy and oral valganciclovir as maintenance therapy. The patient responded to treatment and showed no recurrence for 8 months. There were no serious adverse effects associated with oral valganciclovir. Oral valganciclovir is convenient and effective for the management of CMV retinitis in the patient with Wegener's granulomatosis.
11